Quick answer
Published GHK-Cu wound research falls into three assay types: fibroblast culture readouts (collagen synthesis, MMP-2 and TIMP release, TNF-alpha-driven IL-6), a rat ischemic open-wound model that tracked wound area and tissue TNF-alpha, MMP-2 and MMP-9 over 13 days, and generic migration assays such as the scratch assay. A well-designed GHK-Cu experiment needs a vehicle, a free-peptide arm and a copper-salt arm, because copper alone reproduced some effects. Reported results come from cells and rats and say nothing about people. For laboratory research use only; not for human consumption.
Most pages on this topic summarize results. This article looks at the methods behind them, which is what a laboratory needs in order to repeat or extend the work. It sets out which assays the published GHK-Cu wound studies used, what each can measure, the controls those designs required and the points where the evidence is thin. A companion piece, the GHK-Cu research overview, covers the compound broadly, while this one stays with wound-related experimental design. The reagent is on the GHK-Cu product page, supplied for laboratory research use only.
Why GHK-Cu entered wound research
The rationale is mostly structural and historical. GHK is a tripeptide that was isolated from human plasma and has high affinity for copper (Pickart and colleagues, 2012). A GHK triplet is present in the alpha-2 chain of type I collagen, so Maquart and colleagues suggested that the peptide might be liberated by proteases when tissue is damaged and then act locally (Maquart and colleagues, 1988). That hypothesis, which is a proposal and not a demonstrated fact, is the reason the compound is studied in assays of extracellular-matrix production and remodeling.
Assay 1: fibroblast collagen synthesis
Maquart and colleagues measured collagen output in fibroblast cultures exposed to GHK-Cu. Stimulation began between 10−12 and 10−11 M, was maximal at 10−9 M and did not depend on a change in cell number (Maquart and colleagues, 1988). Three design lessons follow. First, the concentration range is wide and spans several orders of magnitude, so a single-point experiment can miss both the threshold and the peak. Second, the authors checked cell number, which separates a synthesis effect from a proliferation effect and should be part of any repeat. Third, the readout was collagen production by cultured fibroblasts, a surrogate for wound matrix deposition, not wound closure itself.
Assay 2: matrix remodeling by MMPs and TIMPs
Siméon and colleagues asked whether GHK-Cu changes the enzymes that remodel matrix. In dermal fibroblasts it raised MMP-2 in conditioned media with a rise in MMP-2 mRNA, and it increased secretion of TIMP-1 and TIMP-2. The copper-ion control reproduced the MMP-2 stimulation but the tripeptide alone did not (Siméon and colleagues, 2000). Their conclusion was that GHK-Cu acts on remodeling as well as on production of connective tissue. For a bench design, this paper shows why a copper-salt arm is not optional, and why both protein (conditioned medium) and transcript (mRNA) are worth measuring.
Assay 3: inflammatory signaling in fibroblasts
Gruchlik and colleagues stimulated normal human dermal fibroblasts with TNF-alpha and measured IL-6 secretion by ELISA. GGH, GHK, CuCl2 and the copper complexes all decreased TNF-alpha-dependent IL-6 secretion (Gruchlik and colleagues, 2012). The authors point out that IL-6 matters for normal wound healing, so a decrease cannot simply be labelled beneficial or harmful. The readout is a signaling marker, and its meaning depends on the stage of healing being modeled, which an isolated monolayer cannot capture.
Assay 4: the rat ischemic open-wound model
The in vivo paper in this set is Canapp and colleagues' study in 24 adult male rats. Six-millimeter full-thickness wounds were made in an ischemic bipedicle skin flap, and rats were assigned to topical tripeptide-copper complex, the topical vehicle (a hydroxypropyl-methylcellulose gel) or no exposure. Wound margins were traced daily for 13 days, and biopsies on days 6, 10 and 13 were analyzed for TNF-alpha, MMP-2 and MMP-9. Wound area decreased significantly in the complex group compared with no exposure on several day ranges, and by day 13 initial area had fallen by 64.5% with the complex, 45.6% with vehicle and 28.2% with no exposure. Tissue TNF-alpha, MMP-2 and MMP-9 were lower in complex-exposed wounds than in controls (Canapp and colleagues, 2003).
Two points deserve attention. The vehicle group also improved relative to untreated wounds, which is why the three-arm design matters: part of an apparent effect came from the gel. And the model is an ischemic wound in a rat flap, so it informs on that situation only.
| Assay | System | Readout | Control that was needed | What it cannot show |
|---|---|---|---|---|
| Collagen synthesis | Fibroblast culture | Collagen production, cell number | Cell-number check | Wound closure or tissue organization |
| MMP and TIMP release | Dermal fibroblast culture | MMP-2, TIMP-1, TIMP-2 protein and mRNA | Copper-ion arm; free GHK arm | Which cell types matter in vivo |
| IL-6 secretion | Normal human dermal fibroblast line | TNF-alpha-dependent IL-6 by ELISA | Free peptide and CuCl2 arms | Net effect on healing |
| Ischemic wound | Rat dorsal flap, 24 animals | Wound area; tissue TNF-alpha, MMP-2, MMP-9 | Vehicle and untreated arms | Other species or wound types |
| Scratch assay | Any adherent monolayer | Gap closure over time | Proliferation control | Matrix deposition or tissue repair |
Assay 5: scratch assay as a generic migration readout
The scratch assay is not specific to GHK-Cu, but it is the usual low-cost way to ask whether a reagent changes cell migration. Liang and colleagues describe it as creating a scratch in a monolayer, imaging at the start and at regular intervals and comparing images to quantify migration rate; the whole assay usually takes hours to overnight (Liang and colleagues, 2007). For copper peptides three refinements help: image the same fields at every time point, include a proliferation inhibitor or a short time window so that closure is not just cell division, and use a copper-matched control. Because the assay reports on a single cell type on plastic, it is a screen, and a positive result should be followed by a model that includes matrix.
Choosing concentrations and preparing stocks
Published cell work spans picomolar to nanomolar effects (Maquart and colleagues, 1988), so a stock should be planned for serial dilution. The product page lists 50 mg and 100 mg vials; the concentration of any stock is vial mass in mg divided by diluent volume in mL, and molarity is that figure in g/L divided by the molecular weight of the species used. A 100 mg vial in 10 mL, for example, gives 10 mg/mL, which is about 25 mM using a weight of roughly 400 g/mol for the complex. The reconstitution calculator performs the arithmetic, and the details of diluents and buffers are in GHK-Cu in bacteriostatic water. Avoid phosphate buffer and chelators in the stock, and keep the stock cold and dark. For the chemistry behind that advice, see the article on what GHK-Cu is at the molecular level.
A three-arm design sketch for a fibroblast experiment
The layout below combines the controls that the published papers made necessary. It illustrates design logic and is not a validated protocol.
| Arm | Content | Question it answers |
|---|---|---|
| 1. Vehicle | Diluent at the same final volume fraction as the test arms | Baseline and diluent effect |
| 2. GHK-Cu series | Several concentrations across the range in which Maquart and colleagues saw effects | Presence of a concentration-response shape, threshold and peak |
| 3. Free GHK series | Peptide alone at matched peptide concentrations | Whether the effect needs copper |
| 4. Copper salt series | Copper at the copper concentrations delivered in arm 2 | Whether copper alone reproduces the effect |
| 5. Inflammatory challenge (optional) | TNF-alpha with and without arms 2–4 | Whether IL-6 changes follow the pattern reported in dermal fibroblasts |
Run each arm in replicate wells on more than one plate and, where possible, in more than one fibroblast batch, because primary and cell-line fibroblasts differ. Read collagen, MMP-2 and TIMP in conditioned medium collected over the same time window, count cells at the end, and keep the medium composition identical across arms. Record the vial lot, the stock date and the freeze-thaw count of each aliquot so that a later change in response can be traced to the reagent or to the cells.
Reporting standards that make wound-assay results usable
A report that others can repeat states the cell type and passage, the medium and serum level, the concentration of every arm, the exposure time, the assay method with its detection range, the number of independent experiments, and the lot and certificate of the reagent. For animal work it adds species, sex, age, wound size and location, randomization, whether measurements were blinded, and the vehicle composition. The Canapp study illustrates why: the vehicle-only group differed from the untreated group, and without it part of the gel's effect would have been attributed to the peptide complex (Canapp and colleagues, 2003). Even a short methods table in the supplement prevents most reproducibility problems.
Evidence gaps to design around
- Most mechanistic evidence comes from a small set of laboratories, and independent replication of individual findings is limited in the abstracts reviewed.
- A review of the research line describes tissue repair effects across skin, lung, bone, liver and stomach (Pickart and Margolina, 2018), but a review is a secondary source; check the primary paper behind each statement.
- Culture medium composition (serum, albumin, amino acids) changes how much copper is free, so the medium should be stated and kept constant between arms.
- Abstracts do not always give the number of replicates, which should be checked in the full paper before sizing a repeat.
- No study cited here tests GHK-Cu in the same experiment alongside other wound-related peptides. That question is addressed in the article on the GLOW stack and individual components.
Material quality is the last variable. Check the lot's HPLC and identity record on the COA page and the guidance in GHK-Cu purity testing before starting a long series.
Related reading
- GHK-Cu research overview
- GHK-Cu copper peptide research
- GHK-Cu in bacteriostatic water
- GHK-Cu purity testing
- Where to buy GHK-Cu for research
- Research peptide catalog
Frequently asked questions
Which assays are used in published GHK-Cu wound studies?
Fibroblast culture assays for collagen synthesis, MMP-2 and TIMP release and TNF-alpha-dependent IL-6 secretion, and a rat ischemic open-wound model with wound-area tracing and tissue biomarkers.
What concentrations stimulated collagen synthesis in fibroblast cultures?
Stimulation began between 10^-12 and 10^-11 M and peaked at 10^-9 M in the original report, and it was independent of cell number.
Why include a copper-salt control?
In dermal fibroblasts, MMP-2 stimulation was reproduced by copper ions but not by GHK alone, so a copper-only arm separates metal effects from peptide effects.
What did the rat ischemic wound study measure?
Wound area traced for 13 days and, on days 6, 10 and 13, tissue TNF-alpha, MMP-2 and MMP-9, comparing the complex with vehicle and with no exposure.
Does a lower IL-6 level mean better wound repair?
Not necessarily. IL-6 is important for normal wound healing, and the cell study measured a decrease in TNF-alpha-dependent secretion without modeling the stages of repair.
Is the scratch assay enough to study GHK-Cu?
It is a screen for migration on one cell type. Positive results should be followed by models that include extracellular matrix and by readouts of matrix production.
Do these studies apply to people?
No. They describe cells and rats, and GHK-Cu is supplied for laboratory research use only.
Related reading: Collagen and Wound Closure Assays: GHK-Cu, TB-500, Copper Peptide Handling Mistakes and How to Avoid Them, GHK-Cu Anti-Inflammatory Research: Cytokine Models.
References
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-6. doi:10.1016/0014-5793(88)80509-x
- Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257-65. doi:10.1016/s0024-3205(00)00803-1
- Gruchlik A, Jurzak M, Chodurek E, Dzierzewicz Z. Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-alpha-dependent IL-6 secretion in normal human dermal fibroblasts. Acta Pol Pharm. 2012;69(6):1303-6. PMID:23285694
- Canapp SO Jr, Farese JP, Schultz GS, Gowda S, Ishak AM, Swaim SF, et al.. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. 2003;32(6):515-23. doi:10.1111/j.1532-950x.2003.00515.x
- Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2(2):329-333. doi:10.1038/nprot.2007.30
- Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. doi:10.1155/2012/324832
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987
